IL17A and COVID-19: Furthermore, IL-17 is a potent neutrophil chemokine and increased absolute neutrophil number, percentage of neutrophils, and neutrophil: lymphocyte ratio in the blood of COVID-19 patients are predictive of progression to severe disease (41).